Zelira Therapeutics Ltd (ZLD.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ZLD.AX | ||||
| Company | Zelira Therapeutics Ltd | ||||
| Price Information | |||||
| Exchange | ASX | ||||
| Open | 0.500 | ||||
| High | 0.500 | ||||
| Low | 0.485 | ||||
| Latest | 0.500 | ||||
| Change | unch | ||||
| % Change | unch | ||||
| Volume | 19,140 | ||||
| 20-Day Average Volume | 10,153 | ||||
| Previous Close | 0.500 | ||||
| Industry | N/A | ||||
| Has Options | No | ||||
| Technicals | |||||
| 20-Day Moving Average | 0.601 | ||||
| 20-Day Raw Stochastic | 5.77% | ||||
| 20-Day Relative Strength | 45.21 | ||||
| Weighted Alpha | -55.76 | ||||
| Today's Opinion | 64% Buy | ||||
| Previous Opinion | 64% Buy | ||||
| Last Month's Opinion | 56% Buy | ||||
| Performance | |||||
| 5-Days | |||||
| %Chg | -13.79% since 02/17/26 | ||||
| Low | 0.485 on 02/27/26 | ||||
| High | 0.570 on 02/20/26 | ||||
| 1-Month | |||||
| %Chg | -31.03% since 01/27/26 | ||||
| Low | 0.485 on 02/27/26 | ||||
| High | 0.745 on 01/28/26 | ||||
| 3-Month | |||||
| %Chg | +44.93% since 11/27/25 | ||||
| Low | 0.330 on 12/04/25 | ||||
| High | 1.150 on 01/19/26 | ||||
| 6-Month | |||||
| %Chg | +19.05% since 08/26/25 | ||||
| Low | 0.310 on 10/28/25 | ||||
| High | 1.150 on 01/19/26 | ||||
| Key Statistics | |||||
| Market Capitalization, $K | 5,949 | ||||
| Shares Outstanding, K | 11,897 | ||||
| Annual Sales | 656 | ||||
| Annual Net Income | -3,627,872 | ||||
| Last Quarter Sales | N/A | ||||
| Last Quarter Net Income | N/A | ||||
| 60-Month Beta | N/A | ||||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | ||||
| Earnings Date | N/A | ||||
| Most Recent Dividend | N/A | ||||
| Next Ex-Dividends Date | N/A | ||||
| Ratios | |||||
| Price/Earnings ttm | N/A | ||||